Detalhe da pesquisa
1.
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications".
Biomed Res Int
; 2023: 9757348, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37065720
2.
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
Biomed Res Int
; 2021: 9996193, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34676266
3.
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Expert Rev Pharmacoecon Outcomes Res
; 21(4): 527-540, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535841
4.
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
Front Pharmacol
; 8: 497, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28878667
5.
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.
Front Pharmacol
; 7: 305, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733828
6.
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.
Front Pharmacol
; 4: 39, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23717279